ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
-0.43%
Brent Oil
83.76
0.00%
Bitcoin
66,998.62
-0.12%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Immunocore Holdings PLC (IMCR)

  7. Immunocore Holdings PLC (IMCR) Noticias

IMCR Immunocore Holdings PLC

53.29
-0.96 (-1.77%)
Fuera de horario
Última actualización: 16:30:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Immunocore Holdings PLC IMCR NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.96 -1.77% 53.29 16:30:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
54.62 53.195 55.07 53.29 54.25
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/5/202406:13EDGAR2Form 8-K - Current report
08/5/202406:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202406:00GLOBEImmunocore reports first quarter financial results and..
24/4/202409:00GLOBEImmunocore announces upcoming presentation and posters at..
04/4/202415:00GLOBEImmunocore to present at upcoming investor conferences
05/3/202415:30GLOBEImmunocore presented two posters at CROI 2024
01/3/202406:00GLOBEImmunocore to present at upcoming investor conferences
28/2/202415:19EDGAR2Form 8-K - Current report
28/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202406:34GLOBEImmunocore reports fourth quarter and full year 2023..
28/2/202406:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202417:46EDGAR2Form 144 - Report of proposed sale of securities
22/2/202406:00GLOBEImmunocore announces clinical trial collaboration and supply..
21/2/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202406:00GLOBEImmunocore to report fourth quarter and full year 2023..
02/2/202415:05EDGAR2Form 8-K - Current report
30/1/202422:30GLOBEImmunocore Prices Upsized Convertible Senior Notes Offering
29/1/202416:06EDGAR2Form 8-K - Current report
29/1/202415:05GLOBEImmunocore Announces Proposed Convertible Senior Notes..
05/1/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202406:19EDGAR2Form 8-K - Current report
05/1/202406:00GLOBEImmunocore announces strategic priorities and pipeline..
03/1/202416:55EDGAR2Form 144 - Report of proposed sale of securities
03/1/202406:00GLOBEImmunocore to present at the 42nd Annual J.P. Morgan..
02/1/202415:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202405:25EDGAR2Form 8-K - Current report
27/12/202316:30EDGAR2Form 144 - Report of proposed sale of securities
20/12/202312:54EDGAR2Form 144 - Report of proposed sale of securities
30/11/202319:33EDGAR2Form 144 - Report of proposed sale of securities
30/11/202303:00GLOBELevicept Appoints Eliot Forster as CEO
16/11/202308:51EDGAR2Form 144 - Report of proposed sale of securities
07/11/202306:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202306:00GLOBEImmunocore Reports Third Quarter 2023 Financial Results and..
06/11/202318:20EDGAR2Form 144 - Report of proposed sale of securities
01/11/202315:01GLOBEImmunocore announces upcoming poster presentations at SITC..
30/10/202315:30GLOBEImmunocore to present at upcoming investor conferences
21/10/202307:45GLOBEImmunocore presents three-year overall survival data from..
06/10/202306:01GLOBEImmunocore announces upcoming presentation and posters at..
02/10/202315:31EDGAR2Form 144 - Report of proposed sale of securities
11/9/202316:00GLOBEImmunocore to present at upcoming investor conferences
01/9/202315:00GLOBEImmunocore to present at upcoming investor conferences
25/8/202317:10EDGAR2Form 144 - Report of proposed sale of securities
17/8/202314:44EDGAR2Form 144 - Report of proposed sale of securities
10/8/202307:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/8/202306:00GLOBEImmunocore Reports Second Quarter 2023 Financial Results and..
03/8/202307:00GLOBEImmunocore to report second quarter 2023 financial results..
14/7/202315:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

NASDAQ
IMCR
Immunocore
COIN
SALETH
BITMOT
970860
Cct-Eu Tv Eur6m+0,8% Ot2...
NASDAQ
AMAJX
Small Cap Dividend R Class
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados